EKOSCHEMATY JAKO NOWE NARZĘDZIE WSPARCIA ROLNICTWA – STAN REALIZACJI W POLSCE
RePEc: Research Papers in Economics · 01.01.2023
DOI: 10.22004/ag.econ.340043 ↗Kurz gefasst
Fachartikel in der Zeitschrift RePEc: Research Papers in Economics, erschienen am 01.01.2023. Verfasst von Wojciech Styburski und 2 weiteren Autor:innen.
Abstract (Originalsprache)
The article outlines the changes to the EU’s Common Agricultural Policy for 2023-2027 with a particular focus on a new type of direct payment, i.e. ecoschemes. The aim of the article is also to present the interest of farmers in this tool for obtaining funds in the initial period of its operation, i.e. in the first half of 2023. The level and spatial differentiation of interest of Polish farmers in this new type of direct payments was analyzed. It was indicated that the number of applications submitted is influenced by the production specialization of individual provinces. The results of the study further confirm that carbon farming is the most popular of the five types of ecoschemes, with practices such as mixing straw into the soil (61.2%), using winter intercrops/intercrops (35.0%) and mixing manure on arable land within 12 hours of application (23.8%). This state of affairs was influenced by the previous experience of farmers related to the improvement of soil structure.
Schlagwörter
Zitieren
APA
Styburski, W., Kozera, M., & Uglis, J. (2023). EKOSCHEMATY JAKO NOWE NARZĘDZIE WSPARCIA ROLNICTWA – STAN REALIZACJI W POLSCE. RePEc: Research Papers in Economics. https://doi.org/10.22004/ag.econ.340043
Vancouver
Styburski W, Kozera M, Uglis J. EKOSCHEMATY JAKO NOWE NARZĘDZIE WSPARCIA ROLNICTWA – STAN REALIZACJI W POLSCE. RePEc: Research Papers in Economics. 2023. doi:10.22004/ag.econ.340043
BibTeX
@article{Styburski2023,
author = {Styburski, Wojciech and Kozera, Magdalena and Uglis, Jarosław},
title = {EKOSCHEMATY JAKO NOWE NARZĘDZIE WSPARCIA ROLNICTWA – STAN REALIZACJI W POLSCE},
journal = {RePEc: Research Papers in Economics},
year = {2023},
doi = {10.22004/ag.econ.340043}
}
EUVIMED